Drug Shortage Report for TRILEPTAL 300 MG

Last updated on 2019-03-07 History
Report ID 76783
Drug Identification Number 02242068
Brand name TRILEPTAL 300 MG
Common or Proper name TRILEPTAL 300MG 5X10
Company Name NOVARTIS PHARMACEUTICALS CANADA INC
Market Status MARKETED
Active Ingredient(s) OXCARBAZEPINE
Strength(s) 300MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 5 X 10
ATC code N03AF
ATC description ANTIEPILEPTICS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2019-02-25
Estimated end date 2019-03-05
Actual end date 2019-03-06
Shortage status Resolved
Updated date 2019-03-07
Company comments Limited supply available
Health Canada comments
Tier 3 Status No
Contact Address 700 RUE SAINT-HUBERT
MONTREAL, QUEBEC
CANADA H2Y 0C1
Company contact information customer.relations@novartis.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2019-03-07 English Compare
v8 2019-03-06 French Compare
v7 2019-03-06 English Compare
v6 2019-02-26 English Compare
v5 2019-02-25 French Compare
v4 2019-02-25 English Compare
v3 2019-02-25 French Compare
v2 2019-02-25 English Compare
v1 2019-02-25 English Compare

Showing 1 to 9 of 9